Oncology will lead AI-based clinical trials solution provider sales through 2036 with 31.7% of the therapeutic applications segment in 2026. The market was valued at USD 2.51 billion in 2025 and is expected to be worth USD 10.94 billion by 2036, creating an incremental opportunity of USD 8.07 billion.